{
    "2020-10-28": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Amgenâ€™s Earnings and Sales Climb, Driven by Its Biosimilars",
                "features": {
                    "keywords": [
                        "earnings",
                        "sales",
                        "biosimilars"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund",
                "features": {
                    "keywords": [
                        "trades",
                        "health sciences fund"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Will Humira, Cancer Drugs Drive AbbVie (ABBV) Q3 Earnings?",
                "features": {
                    "keywords": [
                        "humira",
                        "cancer drugs",
                        "abbvie",
                        "q3 earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "AbbVie Highlights Innovative Research for People with Rheumatic Diseases with New Data at ACR Convergence 2020",
                "features": {
                    "keywords": [
                        "abbvie",
                        "rheumatic diseases",
                        "research",
                        "acr convergence"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "research"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia",
                "features": {
                    "keywords": [
                        "allergan",
                        "abbvie",
                        "phase 3 results",
                        "agn-190584",
                        "presbyopia"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "clinical trials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}